Current Report Filing (8-k)
December 09 2022 - 8:46AM
Edgar (US Regulatory)
false12-310001506492NASDAQ00015064922022-12-092022-12-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 9, 2022
Nuwellis, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware
|
001-35312
|
No. 68-0533453
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
12988 Valley View Road,
Eden Prairie, MN 55344
(Address of Principal Executive Offices) (Zip Code)
(952) 345-4200
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.0001 per share
|
NUWE
|
Nasdaq Capital Market
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.03 |
Material Modification to Rights of Security Holders.
|
To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this report is
incorporated herein by reference.
Item 5.03 |
Amendment to Articles of Incorporation or Bylaws, Change in Fiscal Year.
|
On December 5, 2022, Nuwellis, Inc. (the “Company”) held a special meeting of stockholders (the “Special Meeting”). At the Special Meeting, the stockholders approved the proposal
to amend the Company’s Fourth Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to effect a reverse stock split of
its outstanding common stock at a ratio in the range of one-for-fifty to one-for-one hundred, to be determined at the discretion of the Board of Directors of the Company (the “Board”
).
On December 8, 2022 following the Special Meeting, the Board approved a one-for-one hundred reverse stock
split of the Company’s issued and outstanding shares of common stock (the “Reverse Stock Split”). On December 9, 2022, the Company filed with the Secretary of State
of the State of Delaware a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split. The
Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on December 9, 2022, and the Company’s common stock will begin trading on a split-adjusted basis when the market opens on December 12, 2022.
When the Reverse Stock Split becomes effective, every one hundred shares of the Company’s issued and
outstanding common stock (and such shares held in treasury) will automatically be converted into one share of common stock, without any change in the par value per share. In addition, a proportionate adjustment will be made to the per share
exercise price and the number of shares issuable upon the conversion of the Company’s outstanding shares of preferred stock and exercise of all outstanding stock options, restricted stock units and warrants to purchase shares of common stock and
the number of shares reserved for issuance pursuant to the Company’s equity incentive compensation plans. Any fraction of a share of common stock that would be created as a result of the Reverse Stock Split will be rounded down to the next whole
share and the stockholder will receive cash equal to the market value of the factional share, determined by multiplying such fraction by the closing sales price of the Company’s common stock as reported on Nasdaq on the last trading day before
the Reverse Stock Split becomes effective.
The Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “NUWE.”
The new CUSIP number for common stock following the Reverse Stock Split will be 67113Y 405.
American Stock Transfer & Trust Company, the Company’s transfer agent, will act as the exchange agent
for the Reverse Stock Split.
For more information about the Reverse
Stock Split, see the Company’s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission and mailed to the Company’s stockholders on or about November 7, 2022, the relevant portions of which are incorporated herein by reference.
A copy of the Certificate of Amendment is attached as Exhibit 3.1 hereto and incorporated herein by reference.
Item 9.01 |
Financial Statements and Exhibits.
|
(d) Exhibits
Exhibit Number
|
Description
|
|
|
|
Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation, as amended, of Nuwellis, Inc.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
Date: December 9, 2022
|
NUWELLIS, INC.
|
|
|
|
By:
|
/s/ Nestor Jaramillo, Jr
|
|
|
Name:
|
Nestor Jaramillo, Jr. |
|
Title:
|
President and Chief Executive Officer |
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Oct 2024 to Nov 2024
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Nov 2023 to Nov 2024